Provost Jean-Claude has filed 5 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 546 shares of Lantheus Holdings, Inc. ($LNTH) on March 05, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2024 | Lantheus Holdings, Inc. | $LNTH | Provost Jean-Claude | Chief Medical Officer | F | Common Stock | 546 | $65.36 | 38,841.0000 | 70,239,000 | 1.39% | 0.00% |
| March 1, 2024 | Lantheus Holdings, Inc. | $LNTH | Provost Jean-Claude | Chief Medical Officer | A | Common Stock | 18564 | $0.00 | 39,387.0000 | 70,239,000 | 89.15% | 0.03% |
| March 1, 2024 | Lantheus Holdings, Inc. | $LNTH | Provost Jean-Claude | Chief Medical Officer | A | Stock Option (right to buy) | 10998 | $0.00 | 10,998.0000 | 70,239,000 | 9999.99% | 0.02% |
| March 2, 2023 | Lantheus Holdings, Inc. | $LNTH | Provost Jean-Claude | Chief Medical Officer | A | Common Stock | 16359 | $0.00 | 20,823.0000 | 70,671,000 | 366.47% | 0.02% |
| March 2, 2023 | Lantheus Holdings, Inc. | $LNTH | Provost Jean-Claude | Chief Medical Officer | A | Stock Option (right to buy) | 9535 | $0.00 | 9,535.0000 | 70,671,000 | 9999.99% | 0.01% |